These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11981279)

  • 1. Update on chemoradiotherapy for head and neck cancer.
    Argiris A
    Curr Opin Oncol; 2002 May; 14(3):323-9. PubMed ID: 11981279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?
    Bourhis J; Lefebvre JL; Vermorken JB
    Eur J Cancer; 2010 Jul; 46(11):1979-89. PubMed ID: 20561781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiotherapy for the treatment of regionally advanced head and neck cancers.
    Aisner J; Jacobs M; Sinabaldi V; Gray W; Eisenberger M
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):35-44. PubMed ID: 7992065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
    Vokes EE; Haraf DJ; Kies MS
    Semin Oncol; 2000 Aug; 27(4 Suppl 8):34-8. PubMed ID: 10952436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of combined modality therapies for head and neck cancer.
    Dimery IW; Hong WK
    J Natl Cancer Inst; 1993 Jan; 85(2):95-111. PubMed ID: 8418313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current and future state of chemoradiotherapy for head and neck cancer].
    Fuwa N
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Feb; 62(2):65-72. PubMed ID: 11905034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemoradiation paradigm in head and neck cancer.
    Seiwert TY; Salama JK; Vokes EE
    Nat Clin Pract Oncol; 2007 Mar; 4(3):156-71. PubMed ID: 17327856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.
    Argiris A; Haraf DJ; Kies MS; Vokes EE
    Oncologist; 2003; 8(4):350-60. PubMed ID: 12897332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemoradiotherapy for patients with advanced head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoradiotherapy: emerging treatment improvement strategies.
    Milas L; Mason KA; Liao Z; Ang KK
    Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma.
    Krstevska V
    J BUON; 2009; 14(3):361-73. PubMed ID: 19810125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer.
    Watkins JM; Zauls AJ; Wahlquist AH; Shirai K; Garrett-Mayer E; Gillespie MB; Day TA; Sharma AK
    Laryngoscope; 2010 Feb; 120(2):236-42. PubMed ID: 19950378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy for head and neck cancer: will history repeat itself?
    Argiris A
    J Natl Compr Canc Netw; 2005 May; 3(3):393-403. PubMed ID: 16002005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of platinum chemotherapy in head and neck cancer.
    Forastiere AA
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):20-7. PubMed ID: 7527591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
    Vokes EE; Kies MS; Haraf DJ; Stenson K; List M; Humerickhouse R; Dolan ME; Pelzer H; Sulzen L; Witt ME; Hsieh YC; Mittal BB; Weichselbaum RR
    J Clin Oncol; 2000 Apr; 18(8):1652-61. PubMed ID: 10764425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined-modality therapy for head and neck cancer.
    Fu KK
    Oncology (Williston Park); 1997 Dec; 11(12):1781-90, 1796; discussion 1796, 179. PubMed ID: 9436185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy for head and neck cancer: recent data.
    Vokes EE
    Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined-modality therapy for locoregionally advanced head and neck cancer.
    Cmelak AJ; Murphy BA; Day T
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):83-91. PubMed ID: 10550831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.